SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna is trending as investors react to reports of early-stage research into an mRNA vaccine targeting Hantavirus, fueling speculation about potential pandemic-related demand. The community is actively debating the company's long-term mRNA platform pipeline, the potential for a short squeeze, and the implications of renewed interest in biosecurity and vaccine development.

The Ondo Foundation was founded in 2022 as an independently governed and nonprofit Cayman Islands Foundation Company with no beneficial owners. The Ondo Foundation assisted in the launch of the Ondo DAO, which deployed and currently governs Flux Finance, the first lending protocol supporting tokenized securities as collateral.  ONDO token holders are entrusted with shaping the future of the Ondo DAO so that it continues to pursue its mission to democratize access to institutional-grade finance. The Ondo DAO gives ONDO holders specific rights pertaining to Flux Finance, which is currently governed by the Ondo DAO.

Ondo

Ondo is trending following a significant legal victory where the SEC closed its investigation into the company without charges, fueling optimism among investors about its regulatory standing in the real-world asset (RWA) sector. Community sentiment is deeply divided, with bulls highlighting the project's institutional partnerships and potential for mass tokenization, while others remain frustrated by persistent price stagnation, upcoming token unlocks, and concerns over heavy circulating supply.

Hormel Foods Corp. engages in the manufacturing and marketing of branded food products. It operates through the following segments: Retail, Foodservice, and International. The Retail segment consists of the processing, marketing, and sale of food products sold predominantly in the retail market. The Foodservice segment includes the processing, marketing, and sale of food and nutritional products for foodservice, convenience store, and commercial customers. The International segment focuses on processing, marketing, and selling company products internationally. The company was founded by George A. Hormel in 1891 and is headquartered in Austin, MN.

Hormel Foods Corp.

Hormel Foods is trending as investors weigh its defensive status and dividend yield against significant margin pressures caused by volatile commodity costs and production challenges. The community is actively debating the stock's long-term value at current levels, with many focusing on whether these headwinds represent a buying opportunity for a dividend aristocrat or a sign of deeper operational struggles.

Conagra Brands, Inc. engages in the manufacture and sale of processed and packaged foods. It operates through the following segments: Grocery and Snacks, Refrigerated and Frozen, International, and Foodservice. The Grocery and Snacks segment includes branded, and shelf stable food products sold in various retail channels in the United States. The Refrigerated and Frozen segment is composed of branded, and temperature-controlled food products sold in various retail channels in the United States. The International segment offers branded food products in various temperature states, sold in various retail and foodservice channels outside of the United States. The Foodservice segment focuses on branded and customized food products, including meals, entrees, sauces, and a variety of custom-manufactured culinary products packaged for sale to restaurants and other foodservice establishments in the United States. The company was founded by Alva Kinney and Frank Little in 1919 and is headquartered in Chicago, IL.

Conagra Brands Inc

Conagra Brands is attracting attention as investors rotate toward undervalued consumer staples, driven by the stock's significant dividend yield and a recent leadership transition to a new CEO. While some remain cautious due to ongoing margin pressures and SNAP-related demand headwinds, the community is debating whether the stock is hitting a generational bottom or remains a value trap.

The Kraft Heinz Co. engages in the manufacture and market of food and beverage products. It operates through the North America and International geographical segments. The company was founded on July 2, 2015, and is headquartered in Pittsburgh, PA.

Kraft Heinz Co

Kraft Heinz is trending as investors weigh a new CEO-led strategic pivot against persistent concerns regarding private-label competition and debt. The community is actively debating the stock's potential as a "quality at a discount" turnaround play, supported by an attractive dividend yield and persistent speculation regarding potential M&A activity within the broader packaged food sector.

Vanguard Index Funds - Vanguard S&P 500 ETF

Vanguard S&P 500 ETF

The S&P 500 is experiencing heightened volatility as investors weigh resilient corporate earnings and AI-driven growth against ongoing geopolitical instability in the Middle East. While many retail investors continue to favor VOO as a core long-term vehicle for dollar-cost averaging, community sentiment remains divided between those betting on market resilience and those anticipating deeper pullbacks amid concerns over potential energy supply shocks and broader economic uncertainty.

Willow Lane Acquisition Corp. is a blank check company, which engages for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded on July 3, 2024 and is headquartered in New York, NY.

Willow Lane Acquisition Corp. - Ordinary Shares - Class A

Willow Lane Acquisition Corp. is trending as investors focus on its upcoming merger with Boost Run, an AI infrastructure provider that recently secured a major hardware agreement with Dell Technologies. Community discussion is centered on the company's high growth projections, its NVIDIA-certified cloud status, and the potential for a significant stock price movement following the transition to the new ticker symbol $BRUN.

XRP is a decentralized digital asset and the native token of the XRP Ledger, a Layer 1 blockchain designed for high-performance global payments. Its primary value proposition is offering a fast, cost-effective alternative to traditional banking systems by enabling near-instant cross-border settlements that finalize in three to five seconds. By serving as a neutral bridge asset between different fiat currencies, it helps financial institutions lower liquidity costs and eliminates the need for pre-funded accounts.  The network is unique because it utilizes a federated consensus protocol instead of energy-intensive mining or staking. This system achieves deterministic finality through a Unique Node List of trusted validators who must reach an eighty percent agreement threshold to permanently record transactions. This infrastructure supports a sustained throughput of 1,500 transactions per second and includes a built-in decentralized exchange that allows for the automated trading of any tokenized asset without intermediaries.  The project traces its origins back to 2004 with Ryan Fugger before being co-founded in its modern form by Jed McCaleb and Chris Larsen. The company, now known as Ripple, works with major financial institutions as partners and investors to build global payment solutions. To protect the network from spam, a small amount of XRP is burned during every transaction, and the token is further utilized by institutions as collateral to access traditional markets and manage digital asset infrastructure.  Institutional adoption of the asset reached a major milestone in November 2025 when the SEC approved the first wave of spot XRP ETFs. These products, offered by major issuers including Bitwise, Grayscale, 21Shares, Canary Capital, and Franklin Templeton, are now listed on prominent exchanges like the NYSE Arca, Nasdaq, and Cboe BZX. While Ripple remains a key contributor to the ecosystem, the underlying XRP Ledger continues to operate as an open-source and decentralized network.

Ripple

XRP is trending as market participants closely monitor the potential passage of the Clarity Act and ongoing institutional integration news. While community sentiment remains divided between hopeful long-term holders awaiting a breakout and frustrated traders highlighting the asset's recent price consolidation, the discourse continues to focus on how upcoming legislative milestones might impact its market trajectory.

Senseonics Holdings, Inc. is a medical technology company, which engages in the development and manufacture of glucose monitoring products. Its primary product is the brand Eversense CGM (continuous glucose monitoring) including sensors, smart transmitters, and mobile applications. The company was founded on June 26, 2014 and is headquartered in Germantown, MD.

Senseonics Holdings Inc

Senseonics Holdings is trending due to investor frustration over a new $80 million stock and warrant offering, which many shareholders view as aggressive dilution that undermines value. The community is actively debating the company's management team and capital-burning business model, as the stock faces downward pressure following this latest financing move.

EchoStar Corp. engages in the design, development, and distribution of digital set-top boxes and products for direct-to-home satellite service providers. It operates through the following business segments: Pay-TV, Retail Wireless, and Broadband and Satellite Services. The Pay-TV segment business strategy is to be the best provider of video services in the United States by providing products with the best technology, outstanding customer service, and great value. The Retail Wireless segment offers Retail Wireless services as well as a competitive portfolio of wireless devices. The Broadband and Satellite Services segment business strategy is to maintain and improve leadership position and competitive advantage through development of technologies and services marketed to selected sectors within the consumer, enterprise and government markets globally. The company was founded by Charlie William Ergen, Candy Ergen, and James DeFranco in 1980 and is headquartered in Englewood, CO.

EchoStar Corp - Ordinary Shares - Class A

EchoStar Corp

EchoStar is currently trending as a primary proxy for SpaceX exposure, with investors focused on the company's significant equity stake and spectrum deals as catalysts for potential value realization ahead of a highly anticipated IPO. Community discussion is dominated by debates over valuation relative to net asset value, speculation regarding potential mergers or acquisitions, and strategic positioning to capture upside from upcoming space sector milestones.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Sionna Therapeutics (NASDAQ:SION) Upgraded to "Strong-Buy" at Wedbush

Wedbush raised Sionna Therapeutics to a "strong-buy" rating in a report on Monday...

Sionna Therapeutics, Inc. $SION Shares Acquired by Jennison Associates LLC

Jennison Associates LLC increased its stake in Sionna Therapeutics, Inc. (NASDAQ:SION - Free Report) by 11.8% in the fourth quarter, according to its most recent 13F filing with the Securities...

JonesTrading Forecasts Strong Price Appreciation for Sionna Therapeutics (NASDAQ:SION) Stock

JonesTrading boosted their target price on Sionna Therapeutics from $52.00 to $63.00 and gave the stock a "buy" rating in a research report on Tuesday...

Sionna Insider Sells $2.5 Million in Stock Amid 215% Surge, but Here's What Investors Should Watch

Key PointsA director of Sionna Therapeutics reported the sale of 55,345 shares for a total transaction value of $2.47 million, using a weighted average price of $44.67 per share across April 17-18, 2026...

Sionna Therapeutics (NASDAQ:SION) Earns "Buy" Rating from BTIG Research

BTIG Research reissued a "buy" rating and set a $58.00 price target on shares of Sionna Therapeutics in a report on Monday...

Sionna Therapeutics (NASDAQ:SION) Stock Price Up 6.7% - Here's What Happened

Sionna Therapeutics (NASDAQ:SION) Stock Price Up 6.7% - Still a Buy...

Sionna Therapeutics (NASDAQ:SION) Stock Price Down 11.3% - What's Next?

Sionna Therapeutics (NASDAQ:SION) Shares Down 11.3% - Here's What Happened...

Sionna Therapeutics (NASDAQ:SION) Director Orbimed Advisors Llc Sells 52,397 Shares

Sionna Therapeutics, Inc. (NASDAQ:SION - Get Free Report) Director Orbimed Advisors Llc sold 52,397 shares of the firm's stock in a transaction on Friday, April 17th. The shares were sold at an average price of $44.68, for a total value of $2,341,097.96. Following the transaction, the director...

Sionna Therapeutics (NASDAQ:SION) Director Peter Thompson Sells 52,397 Shares

Sionna Therapeutics, Inc. (NASDAQ:SION - Get Free Report) Director Peter Thompson sold 52,397 shares of Sionna Therapeutics stock in a transaction on Friday, April 17th. The shares were sold at an...

Sionna Therapeutics (NASDAQ:SION) Director Sells $2,341,097.96 in Stock

Sionna Therapeutics, Inc. (NASDAQ:SION - Get Free Report) Director Orbimed Advisors Llc sold 52,397 shares of Sionna Therapeutics stock in a transaction that occurred on Friday, April 17th. The stock...

Sionna Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The firm engages in researching, developing and commercializing novel medicines for cystic fibrosis. It is focused on advancing a pipeline of small molecules and complementary CFTR modulators designed to deliver transformative clinical outcomes and improve the quality of life for individuals living with cystic fibrosis. The company was founded by Greg Hurlbut and Mark Munson in August 2019 and is headquartered in Waltham, MA.

Sionna Therapeutics Inc.

Up > 1%

Flat +/- 1%

Down > 1%

Where does the $SPY finish next week vs. Friday’s close?

SION
Sionna Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Compact View

Poll

Latest SION News

SIONSionna Therapeutics Inc